Merit Medical(MMSI) ZACKS·2025-02-24 15:21Core Insights - Wall Street analysts anticipate Merit Medical (MMSI) will report quarterly earnings of $0.83 per share, reflecting a year-over-year increase of 2.5% [1] - Expected revenues for the quarter are projected at $349.39 million, which represents a 7.7% increase from the same quarter last year [1] - The consensus EPS estimate has been revised upward by 1% in the last 30 days, indicating a reassessment by covering analysts [1] Revenue Projections - Analysts predict 'Revenue- Cardiovascular- Peripheral Intervention' will reach $141.35 million, indicating a 5.4% increase from the prior-year quarter [4] - 'Revenue- Cardiovascular- Cardiac Intervention' is expected to be $93.51 million, reflecting a 3.6% year-over-year change [4] - 'Revenue- Endoscopy' is projected to reach $17.94 million, suggesting a significant increase of 93.1% year over year [4] Additional Revenue Insights - 'Revenue- Cardiovascular- OEM' is estimated at $46.68 million, indicating a 13.3% increase from the previous year [5] - The total 'Revenue- Cardiovascular' is expected to be $331.43 million, reflecting a year-over-year change of 5.1% [5] - 'Revenue- Cardiovascular- Custom Procedural Solutions' is projected to reach $49.87 million, suggesting a modest increase of 0.5% year over year [6] Stock Performance - Shares of Merit Medical have shown a return of -1.4% over the past month, compared to a -0.5% change in the Zacks S&P 500 composite [6] - With a Zacks Rank 2 (Buy), MMSI is expected to outperform the overall market in the near future [6]